We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPH icon
2351
Five Point Holdings
FPH
$370M
$33K ﹤0.01%
+2,390
New +$33.7K
GAM
2352
General American Investors Company
GAM
$1.6B
$33K ﹤0.01%
916
-289
-24% -$10.1K
HNRG icon
2353
Hallador Energy
HNRG
$698M
$33K ﹤0.01%
+5,845
New +$37.9K
IEV icon
2354
iShares Europe ETF
IEV
$1.69B
$33K ﹤0.01%
700
+291
+71% +$13.3K
JKHY icon
2355
Jack Henry & Associates
JKHY
$11.2B
$33K ﹤0.01%
+324
New +$33.5K
KINS icon
2356
Kingstone Companies
KINS
$301M
$33K ﹤0.01%
1,986
+395
+25% +$6.1K
LBRDK icon
2357
Liberty Broadband Class C
LBRDK
$5.32B
$33K ﹤0.01%
+343
New +$33K
MMI icon
2358
Marcus & Millichap
MMI
$1.2B
$33K ﹤0.01%
+1,211
New +$31.5K
OCUL icon
2359
Ocular Therapeutix
OCUL
$1.92B
$33K ﹤0.01%
+5,275
New +$34K
OLP
2360
One Liberty Properties
OLP
$527M
$33K ﹤0.01%
+1,354
New +$32.6K
PKX icon
2361
POSCO
PKX
$17B
$33K ﹤0.01%
472
-882
-65% -$63.3K
RGCO icon
2362
RGC Resources
RGCO
$228M
$33K ﹤0.01%
+1,150
New +$31.5K
RLGT icon
2363
Radiant Logistics
RLGT
$395M
$33K ﹤0.01%
6,245
+5,108
+449% +$25.5K
XRAY icon
2364
Dentsply Sirona
XRAY
$2.64B
$33K ﹤0.01%
+560
New +$33.3K
TBNK
2365
DELISTED
Territorial Bancorp Inc.
TBNK
$33K ﹤0.01%
1,043
+1,028
+6,853% +$31K
ITI
2366
DELISTED
Iteris, Inc.
ITI
$33K ﹤0.01%
+4,925
New +$30.9K
ALIM
2367
DELISTED
Alimera Sciences
ALIM
$33K ﹤0.01%
+1,636
New +$35K
ZYNE
2368
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$33K ﹤0.01%
3,913
+3,828
+4,504% +$40.5K
NOVN
2369
DELISTED
Novan, Inc. Common Stock
NOVN
$33K ﹤0.01%
582
+391
+205% +$18.6K
ECOM
2370
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$33K ﹤0.01%
+2,907
New +$31.6K
CCXI
2371
DELISTED
ChemoCentryx, Inc.
CCXI
$33K ﹤0.01%
+4,461
New +$37.1K
STML
2372
DELISTED
Stemline Therapeutics, Inc.
STML
$33K ﹤0.01%
2,909
+2,839
+4,056% +$26.7K
NSM
2373
DELISTED
Nationstar Mortgage Holdings
NSM
$33K ﹤0.01%
+1,755
New +$30.6K
MULE
2374
DELISTED
MuleSoft, Inc.
MULE
$33K ﹤0.01%
+1,660
New +$37K
WBKC
2375
DELISTED
Wolverine Bancorp, Inc.
WBKC
$33K ﹤0.01%
775
+674
+667% +$27.2K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.